Literature DB >> 23713944

Role of complement 3a in the growth of mesangial cells from stroke-prone spontaneously hypertensive rats.

Kazuya Ikeda1, Noboru Fukuda, Takahiro Ueno, Morito Endo, Naohiko Kobayashi, Masayoshi Soma, Koichi Matsumoto.   

Abstract

Vascular smooth muscle cells (VSMCs) derived from spontaneously hypertensive rats (SHR) show exaggerated growth with a synthetic phenotype and angiotensin II (Ang II) production associated with increased production of complement (C3). We hypothesized that C3 is involved in the growth of mesangial cells (MCs) from hypertensive rats. We examined the effects of a C3a receptor inhibitor on proliferation, phenotype and Ang II generation in MCs from stroke prone-spontaneously hypertensive rats (SHR)-SP, SHR and Wistar-Kyoto (WKY) rats. Expression of C3 and C3a receptor were evaluated by immunohistochemical staining of the renal cortex. We examined the effects of the C3a inhibitor, SB290157, on proliferation, the expression of phenotype-marker mRNAs and Ang II production in cells from SHR-SP, SHR and WKY rats. Immunostaining of C3 was stronger in SHR and SHRSP glomeruli. MCs from SHR-SP and SHR abundantly express pre-pro C3 mRNA. SB290157 significantly inhibited basal DNA synthesis and proliferation of MCs from SHR-SP and SHR. Expression of osteopontin mRNA in MCs from SHR-SP and SHR was decreased with SB290157 treatment, whereas MC basal expression of α-SMA mRNA was decreased. SB290157 significantly decreased the production of Ang II in MCs from SHR-SP and SHR. Endogenous C3a promotes exaggerated growth with a synthetic phenotype and the production of Ang II in MCs from SHR-SP and SHR. The C3 and C3a receptor system may primarily be involved in the pathogenesis of renal remodeling in hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23713944     DOI: 10.3109/10641963.2013.789042

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  8 in total

Review 1.  Role of complement 3 in the pathogenesis of hypertension.

Authors:  Lan Chen; Noboru Fukuda; Taro Matsumoto; Masanori Abe
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

2.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

3.  The complement system in hypertension and renal damage in the Dahl SS rat.

Authors:  Jean F Regal; Connor F Laule; Luke McCutcheon; Kate M Root; Hayley Lund; Shireen Hashmat; David L Mattson
Journal:  Physiol Rep       Date:  2018-03

4.  Increased Complement 3 With Suppression of miR-145 Induces the Synthetic Phenotype in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats.

Authors:  Lan Chen; Noboru Fukuda; Tomoyasu Otsuki; Sho Tanaka; Yoshihiro Nakamura; Hiroki Kobayashi; Taro Matsumoto; Masanori Abe
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

Review 5.  Genetic Modifications to Alter Blood Pressure Level.

Authors:  Hiroki Ohara; Toru Nabika
Journal:  Biomedicines       Date:  2022-08-01

6.  Twist-related protein 1 induces epithelial-mesenchymal transition and renal fibrosis through the upregulation of complement 3.

Authors:  Tomoyasu Otsuki; Noboru Fukuda; Lan Chen; Akiko Tsunemi; Masanori Abe
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

Review 7.  The Complement System in Metabolic-Associated Kidney Diseases.

Authors:  Ziyu Xu; Li Tao; Hua Su
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

Review 8.  Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Authors:  Meena S Madhur; Fernando Elijovich; Matthew R Alexander; Ashley Pitzer; Jeanne Ishimwe; Justin P Van Beusecum; David M Patrick; Charles D Smart; Thomas R Kleyman; Justin Kingery; Robert N Peck; Cheryl L Laffer; Annet Kirabo
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.